Onyx Pharmaceuticals, Inc., a Subsidiary of Amgen, Inc. Form 483 Details
Form 483Source: FDA inspection recordConfirmed against FDA's published inspection data for this establishment and inspection date. FDA has published the inspection and what it cited, but not the form itself, which usually takes six to twelve months.
To check this against FDA, open FDA's record for this establishment on FDA's Data Dashboard, which lists this inspection under FEI 3009255166.
Onyx Pharmaceuticals, Inc., a Subsidiary of Amgen, Inc.
South San Francisco, California, United States
Issue DateJanuary 20, 2012
FEI Number3009255166
CountryUnited States
Status
No Warning LetterProduct Type
Drugs